About IAC
A-Z Index
Immunization Action Coalition
IAC Home
Technically Speaking
December 2011
Technically Speaking
Monthly Column by Deborah Wexler, MD
Deborah Wexler MD
Technically Speaking is a monthly column written by IAC’s Executive Director Deborah Wexler, MD. The column is featured in The Children's Hospital of Philadelphia Vaccine Education Center’s (VEC's) monthly e-newsletter for healthcare professionals. Technically Speaking columns cover practical topics in immunization delivery such as needle length, vaccine administration, cold chain, and immunization schedules.
Check out a recent issue of Vaccine Update for Healthcare Providers. The VEC e-newsletter keeps providers up to date on vaccine-related issues and includes reviews of recently published journal articles, media recaps, announcements about new resources, and a regularly updated calendar of events.
"Catching-up" Kids – and Don’t Forget the Supplemental Dose of PCV13
Published December 2011
Healthcare providers often encounter children who are behind schedule for recommended vaccines. These children need to be "caught up." Children who are more than one month or one dose behind schedule should be put on an accelerated immunization schedule, which means the intervals between doses should be reduced to the minimum allowable until the child is up to date. Each year, the U.S. recommended child immunization schedule comes with a catch-up schedule that spells out the minimum spacing interval recommended between various vaccine doses.
When children fall behind on their vaccinations, it's best to get them caught up by administering all indicated vaccines at the same appointment. For more information on how to accomplish this, please refer to the December 2010 issue of "Technically Speaking."
Once you have the child back on schedule, counsel the parents about the importance of bringing the child in on time for future vaccinations.
Many children up to age 5 need a supplemental dose of PCV13
In December 2010, ACIP recommended
PCV13 replace PCV7 for the four-dose early childhood series because PCV13 provides broader protection against invasive pneumococcal disease.
A supplemental dose of PCV13 for children ages 14-59 months who have already completed their PCV7 series. This dose will provide protection against the six serotypes not found in PCV7.
Unfortunately, CDC data from five Immunization Information System Sentinel Sites showed that only about half of children ages 12-23 months, and only a quarter of children ages 24-59 months, had received a supplemental dose of PCV13. Moreover, CDC surveillance indicated that the majority of children younger than age 5 years who were reported with invasive pneumococcal disease had not received a supplemental dose of PCV13. Please see the article in the November issue of AAP News, by Larry Pickering, MD, AAP Red® Book editor, on this subject.
So remember, when patients younger than age 5 years come to the office, check their immunization status to make sure that those who are recommended for a supplemental dose of PCV13 receive it. In addition, consider checking charts and recalling children who are behind, so they don't miss this important opportunity for protection against invasive pneumococcal disease.
2011 ISSUES >> view all
"Catching-up" Kids – and Don’t Forget the Supplemental Dose of PCV13
Which Children Need Two Doses of Influenza Vaccine for the 2011-2012 Season?
Screening Patients for Contraindications to Vaccination
Guidance for Busy Clinics on Prefilling Your Own Syringes
Are Your New Patients Missing Their Immunization Records?
JULY 2011
CDC’s “General Recommendations on Immunization” – Make Sure You Have a Copy!
JUNE 2011
Standing Orders Can Help You Vaccinate Your Patients
APRIL 2011
2011 Immunization Schedules Now Available
MARCH 2011
Tdap Recommendations Broadened
Using Vaccine Information Statements (VISs) Correctly
This page was reviewed on May 8, 2012
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 6NH23IP22550) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.